A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications

This randomized clinical trial's goal is to determine SafeBreak Vascular's impact, a break-away connector that separates when a harmful force is placed on a peripheral IV line, on IV clinical care and complications.

Inclusion criteria

• All patients admitted into the participating hospital units
• Patients of any gender may participate
• Participants able to provide informed consent or have a legally authorized representative immediately available to provide informed consent
• Patients must have peripheral IV catheter access or need and are planned to have peripheral IV catheter access placed that is anticipated to last a minimum of 24 hours.
• Patients must be receiving intermittent or continuous infusion or have immediate plans to begin an intermittent or continuous infusion
• The patients must be at least 18 years of age with no upper age limit

Exclusion criteria

• Unable to obtain informed consent or without an available Legally Authorized Representative or Next of Kin to provide surrogate informed consent
• Age less than or equal to 17
• Patient on comfort care only
• Predicted to have an IV infusion that lasts less than 24 hours
• Patient admitted from the Emergency Department refuses to have new peripheral IV catheter placed by IV team
• Patient has two or more peripheral IV catheters at the same time
• Patient enrolled in a subject drug or device study at the time of enrollment
• Investigator discretion that patient is not suitable for the study
• Patient is COVID-19 positive
• Patient is receiving an IV infusion with gravity tubing